BCR and chronic myelogenous leukemia, BCR-ABL1 positive: C-myc expression is increased in K562R cell line resistant to Imatinib, which in turn reduces the expression of miR-144/451.   30  On the other hand, bilateral regulatory loop between BCR-ABL and miR-451 maintains the leukemic state of CML cells.   34